Innovative Therapies Days 2024

9–12 Oct 2024 | BESANCON, France

Stéphane MADDENS

Founder / CEO

VETBIOBANK

Lyon, France

20 profile visitsSpeakerSpeakers

About me

Founder of Vetbiobank - passionate about developing cell therapy as a new way to tackle complex diseases. I see veterinary medicine as a window over human health, our animals and us are sharing so much physiopathological processes.

Previously i was largely involved in R&D and clinical research program in human health related to cell, tissue transplantation, in oncology-oncohaematology and regenerative medicine - at the French Blood Transfusion institute, Hospitals, and also at Vertex Pharmaceuticals.

My organisation

Vetbiobank is a clinical stage biotech specialised in developing and manufacturing GMP cell therapy products for the veterinary market. Our lead drug-candidate targets canine osteoarthritis and is currently under review by EMA for market authorisation. We are also exploring exosomes/microvesicles from mesenchymal strom cells. Open for investments.

Social media

Speaker sessions (1)

Friday, 11 October 2024

14:00 - 15:00

Session #4 : Cell and gene therapies

Format:In-person
Location:Petit Kursaal room
Track:
Conference